Stockreport

NantKwest Announces New haNK Natural Killer Cell Patent Issuance Further Expanding Intellectual Property Estate

NANTKWEST  (NK) 
Last nantkwest earnings: 3/25 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nantkwest.com
PDF New haNK and T-haNK Based Natural Killer Cell Therapy Programs to Transition to Human Clinical Trials in 2019 CULVER CITY, Calif.--(BUSINESS WIRE)- [Read more]